- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04540822
Peripheral Catheter Pressure Ulcer Prevention in Pediatry : Use of Compresses Versus Standard Care (KTESCA)
Peripheral Catheter Pressure Ulcer Prevention in Pediatry : Use of Compresses Versus Standard Care"
Peripheral venous catheterisation is a multi-daily practice in a paediatric ward.
In our pediatrics department, nurses have observed for several years now the appearance of pressure sore-like skin lesions at the junction of the peripheral venous catheter with the extension tube. A ward habit has spontaneously developed of applying a compress under this junction. The objective is to minimize physical or emotional aggression as well as pain. Pain that is denied or not identified and not relieved is memorized by the child, which can have consequences on the perception of pain and the subsequent acceptance of care.
To date, through their reading and research, investigators have been able to find articles mentioning the risks of pressure ulcers in children related to medical devices. However, few elements are developed concerning catheter-related pressure ulcers, especially on this specific technique for preventing injuries at the catheter-extension tube junction. Investigators have not found any recommendations on this subject.
Thus, the aim of this study is to compare two peripheral venous catheter fixation devices, with compress and without compress, and to analyse the frequency of pressure ulcer occurrence and the intensity of this lesion.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
La Roche-sur-Yon, France, 85000
- CHD Vendee
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Aged 1 month to 18 years old, according to the criteria of the paediatrics department of the Departmental Hospital la Roche sur Yon .
- Hospitalized in paediatrics ward or consultant in paediatric emergencies with a high probability of being hospitalized in paediatrics ward later.
- With an indication for the insertion of a short peripheral venous catheter
- Written agreement from the holder(s) of parental authority
Exclusion Criteria:
- Children with dermatological affections prior to inclusion and at the puncture site (atopic dermatitis, skin infection, skin wound, chickenpox, epidermolysis bullosa)
- Allergy to fixation devices
- Known immune deficient child
- Refusal of the patient or of the holders of parental authority to participate
- Life-saving emergency care
- Patient already included in the study
- Patient without social security coverage
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: peripheral venous catheter with compress
Insertion of a peripheral venous catheter with a compress inserted below the catheter-extension tube junction
|
Placement of a BD Insyte® type catheter of 20 to 24 Gauge calibre on a peripheral vein located in the crease of the elbow or top of the hand or scalp or top of the foot.
The catheter is placed while respecting the detersion and disinfection of the skin with the appropriate products and according to the procedure in force in the department.
Once the venous return has been checked, a 10 cm extension with a BECTON-DIC® 3-way valve will be connected, which is previously purged with 0.9% Sodium Chloride.
Under the catheter-extension tube junction will be inserted a sterile non-woven compress, cut sterilely (3.5x1.5 cm).
The assembly will be held in place by a transparent sterile semi-permeable adhesive dressing such as Tegaderm® (5x7 cm).
This area will be secured by placing a crepe bandage (crepe bandage 4 m x7 cm).
|
|
Active Comparator: peripheral venous catheter without compress
Insertion of a peripheral venous catheter without any compress inserted below the catheter-extension tube junction.
|
Placement of a BD Insyte® type catheter of 20 to 24 Gauge calibre on a peripheral vein located in the crease of the elbow or top of the hand or scalp or top of the foot.
The catheter is placed while respecting the detersion and disinfection of the skin with the appropriate products and according to the procedure in force in the department.
Once the venous return has been checked, a 10 cm extension with a BECTON-DIC® 3-way valve will be connected, which is previously purged with 0.9% Sodium Chloride.
No compresses will be inserted under the catheter-extension tube junction.The assembly will be held in place by a transparent sterile semi-permeable adhesive dressing such as Tegaderm® (5x7 cm).
This area will be secured by placing a crepe bandage (crepe bandage 4 m x7 cm).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pressure Ulcer of Grade >=1 on the National Pressure Ulcer Advisory Panel (NPUAP) Scale
Time Frame: at catheter removal
|
Occurrence of a pressure ulcer of grade ≥1 according to the NPUAP scale at the catheter extension junction. A higher grade on this scale indicates a worse patient outcome. The assessment will be performed in a blinded manner by a childcare assistant (CDA) from the department. |
at catheter removal
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pressure ulcer intensity as measured by the NPUAP scale
Time Frame: at catheter removal
|
The NPUAP pressure ulcer rating scale translated in French by the National French Agency for accreditation and assessment of Health (ANAES) will be used.
This scale evaluates pressure ulcers according to 4 stages graduated from 1 to 4. Stage 1 being the least severe.
|
at catheter removal
|
|
dwell time of peripheral venous catheters between the 2 groups
Time Frame: at catheter removal
|
Will be calculated from the time of catheter placement to the time of catheter removal.
|
at catheter removal
|
|
Presence of a nosocomial infection related to the peripheral venous catheter.
Time Frame: at catheter removal +48hours
|
Will be defined as a peripheral venous catheter culture > 10^3 Colony Forming Unit/ml, if the peripheral venous catheter is referred in culture on suspicion of infection and in the absence of antibiotic treatment.
In the presence of antibiotic treatment, it will be defined by the presence of pus and/or regression of infectious signs within 48 hours after removal of the peripheral venous catheter.
|
at catheter removal +48hours
|
Collaborators and Investigators
Investigators
- Study Director: stephanie Chaillot, CHD Vendee
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CHD194-19
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pressure Ulcer
-
McMaster UniversityQueen's University; Kindera Living; Room 217 FoundationNot yet recruitingPressure Injury | Pressure Injuries | Pressure Ulcer (PU)Canada
-
King Abdullah Medical CityRecruitingPressure Injury | Pressure Ulcer, Buttock | Pressure Injury Stage 2 | Pressure Ulcers Stage II | BedsoreSaudi Arabia
-
Fundación para el Fomento de la Investigación Sanitaria...Not yet recruitingPressure Ulcers | Biofilm | Biofilm Formation | Pressure Ulcers Stage III | Pressure Ulcer ( Stage 2-3) | Pressure Ulcer Prevention | Biofilm Removal
-
Applied Biologics, LLCSerenaGroup, Inc.RecruitingPressure Ulcer | Pressure Area | Ulcer, Pressure | Pressure WoundUnited States
-
Nottingham University Hospitals NHS TrustUniversity of Leicester; University of SurreyRecruitingPressure Injuries | Pressure Ulcers, Bedsores, Decubitus UlcerUnited Kingdom
-
Bartın UnıversityCompletedPressure Ulcer Prevention | Pressure Ulcer Prevention Training for Home Care PatientsTurkey (Türkiye)
-
The Cleveland ClinicSuspendedStage 1 Pressure Ulcer | Stage 2 Pressure UlcerUnited States, Austria
-
Prof. Dr. Cemil Tascıoglu Education and Research...CompletedPressure Injuries | Medical Device Related Pressure Ulcer (MDRPU)Turkey (Türkiye)
-
Ruijin HospitalEnrolling by invitationPressure Ulcer PreventionChina
-
Ankara Medipol UniversityDr. Lutfi Kirdar Kartal Training and Research Hospital; Fenerbahce UniversityNot yet recruitingPressure Ulcer (PU)
Clinical Trials on peripheral venous catheter with compress under the catheter-extension tube junction
-
Second Affiliated Hospital, School of Medicine,...Completed
-
University Hospital, MontpellierRecruitingIntensive Care | Newborns | NeonatologyFrance
-
Kahramanmaras Sutcu Imam UniversityCompleted
-
Western Galilee Hospital-NahariyaRecruitingSepsis | HemodialysisIsrael
-
University Hospital, MontpellierNot yet recruitingEustachian Tube Dysfunction
-
Attikon HospitalUnknownPostoperative Pain | Anterior Cruciate Ligament ReconstructionGreece, Italy
-
Hospital Arnau de VilanovaDepartment of Health, Generalitat de Catalunya (PERIS); Official College of...Not yet recruitingThrombosis | Occlusion | Vascular Access Devices | Catheters | Randomised Controlled Trial
-
Aydin Adnan Menderes UniversityCompletedCatheter-Associated InfectionsTurkey
-
University of Sao Paulo General HospitalCompletedFetal Bradycardia | Hypertonic Uterine | CatecholaminesBrazil
-
Sint MaartenskliniekCompletedArthroplasty, Replacement, KneeNetherlands